Tag: AHA
ReCor Medical announces consistent reduction of blood pressure in pooled analysis...
ReCor Medical and its parent company, Otsuka Medical Devices, announced consistent and significant blood pressure-lowering results across a range of patients with uncontrolled hypertension,...
SPYRAL HTN-ON MED study demonstrates meaningful clinical benefits consistent with other...
Medtronic has announced the six-month results from the full cohort of the SPYRAL HTN-ON MED clinical trial. The late-breaking data were presented at the...
Dialyze Direct heralds AHA report endorsing more frequent haemodialysis model of...
Dialyze Direct has welcomed the American Heart Association’s (AHA) recent scientific statement endorsing home dialysis therapies—including the more frequent haemodialysis (MFD) model of care—in...